formestane has been researched along with Prostatic Hyperplasia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartsch, G; el Etreby, MF; Habenicht, UF; Schröder, FH; Schweikert, HU; Senge, T; Tunn, UW | 1 |
| Celotti, F; Lechuga, MJ; Martini, L; Melcangi, RC; Motta, M; Negri-Cesi, P; Poletti, A; Zoppi, S | 1 |
| Henderson, D | 2 |
| el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K; Schweikert, HU | 1 |
| Cocconi, M; Costantini, A; Martini, L; Motta, M; Natali, A; Serio, M; Zoppi, S | 1 |
| el Etreby, MF; Habenicht, UF; Henderson, D; Kerb, U; Nishino, Y | 1 |
| Bartsch, W; Klein, H; Stürenburg, HJ; Voigt, KD | 1 |
| Brodie, AM; Inkster, SE; King, DA; Meyer, KM; Son, C | 1 |
3 review(s) available for formestane and Prostatic Hyperplasia
| Article | Year |
|---|---|
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Humans; Male; Prostatic Hyperplasia; Tamoxifen | 1993 |
Androgen metabolism in different target tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Androstenedione; Animals; Brain; Cricetinae; Dihydrotestosterone; Humans; Male; Pituitary Gland; Prostate; Prostatic Hyperplasia; Rats; Testosterone | 1990 |
Aromatase inhibitors: their biochemistry and clinical potential.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Male; Oxidoreductases; Prostatic Hyperplasia | 1987 |
6 other study(ies) available for formestane and Prostatic Hyperplasia
| Article | Year |
|---|---|
Estrogens and benign prostatic hyperplasia: rationale for therapy with aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estrogens; Humans; Male; Prostatic Hyperplasia | 1991 |
Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Dogs; Estradiol; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1986 |
In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstane-3,17-diol; Androstenedione; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1986 |
Aromatase inhibitors and benign prostatic hyperplasia.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Gonadotropins, Equine; Humans; Kinetics; Male; Prostatic Hyperplasia; Species Specificity | 1986 |
Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Estrone; Humans; Male; Microsomes; Placenta; Prostate; Prostatic Hyperplasia; Testolactone | 1987 |
Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
Topics: Androstenedione; Aromatase; Cholestenone 5 alpha-Reductase; Estrogens; Humans; In Vitro Techniques; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1989 |